Gedeon Richter PLC (BUSE: RICHTER)
Health Care · Pharmaceuticals · HU
Ft12,350.00
+1.23% today · +18.6% 1Y
Gedeon Richter PLC (BUSE: RICHTER) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $6.90B.
Over the last twelve months the share price has gained 18.6%, trading between 9.38K and 13.57K.
Tweenvest scores Gedeon Richter PLC across four factors: quality 90/100, value 56/100, growth 59/100, dividend 100/100. Its strongest factor is dividend.
RICHTER price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $6.90B
- Revenue (TTM)
- $2.97B
- P/E
- 10.46
- EPS
- 1,180.33
- Dividend yield
- 4.16%
- Beta (5Y)
- 0.35
- 52-week high
- Ft13,570.00
- 52-week low
- Ft9,380.00
- Avg volume (3M)
- —
- Shares outstanding
- 182.39M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eisai Co., Ltd.TSE: 4523 | $8.19B | ¥4,603.00 | -0.60% |
| ALK-Abelló A/SCPSE: ALK B | $7.56B | Dkr227.40 | +12.80% |
| Kyowa Kirin Co., Ltd.TSE: 4151 | $7.35B | ¥2,222.50 | +0.61% |
| Amneal Pharmaceuticals, Inc.NasdaqGS: AMRX | $6.93B | $19.91 | +1.32% |
| H. Lundbeck A/SCPSE: HLUN B | $6.76B | Dkr45.96 | -0.35% |
| Ono Pharmaceutical Co., Ltd.TSE: 4528 | $6.70B | ¥2,259.00 | +0.53% |
| Glenmark Pharmaceuticals LimitedNSEI: GLENMARK | $6.69B | Rs2,293.00 | -1.63% |
| Alkem Laboratories LimitedNSEI: ALKEM | $6.52B | Rs5,279.00 | +1.13% |
Figures last refreshed Oct 11, 2026.